News

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.
The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...
Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.
Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...
The Food and Drug Administration is developing a plan to shift more food safety inspections over to state partners over the ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
The mass firing of State Department employees could significantly impact the Trump administration’s ability to address the ...
But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection ...